|
|
|
|
Construction Begins on Cancer Center Expansion
Patient Entrance Relocated
Construction work has begun on a 45,000 square-foot expansion to the Mary Babb Randolph Cancer Center on the campus of West Virginia University.
"A construction fence has been put in place, and exterior preparation has begun," said John E. Prescott, dean of the WVU School of Medicine and interim director of the Cancer Center. "The end result will be a more spacious facility, featuring a clinic twice the size of the existing one, additional exam rooms, larger, more comfortable waiting areas and easier access to hospital services."
The regular entrance to the Cancer Center will be closed beginning December 18.
More Info >
Cancer Center Acquires New Technology
Research Aimed at Individualizing Treatment
Researchers at West Virginia University’s Mary Babb Randolph Cancer Center have acquired cutting edge technology that offers great potential for improving cancer treatment.
The DNA sequencer is a sophisticated device that provides a new approach for studying the molecular characteristics of tumors. The sequencer measures gene variations that are most sensitive to drugs proven effective in targeting cancer cells.
“The goal is to develop targeted treatment strategies that are tailored to patients, based on their genetic pattern,” said William Petros, PharmD, Associate Director for Anti-Cancer Drug Development, and the lead author of a recent article in the Journal of Clinical Oncology. The article linked anti-cancer drug activity to common genetic variations.
More Info >
|
|
